- Home
- DMRC vs NVCT Comparison
DMRC vs NVCT Comparison
Compare DMRC & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DMRC
- NVCT
- Stock Information
- Founded
- DMRC 2008
- NVCT 2020
- Country
- DMRC United States
- NVCT United States
- Employees
- DMRC N/A
- NVCT N/A
- Industry
- DMRC EDP Services
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- DMRC Technology
- NVCT Health Care
- Exchange
- DMRC Nasdaq
- NVCT Nasdaq
- Market Cap
- DMRC 158.2M
- NVCT 167.0M
- IPO Year
- DMRC N/A
- NVCT 2022
- Fundamental
- Price
- DMRC $7.29
- NVCT $6.10
- Analyst Decision
- DMRC Strong Buy
- NVCT Strong Buy
- Analyst Count
- DMRC 1
- NVCT 3
- Target Price
- DMRC $20.00
- NVCT $15.33
- AVG Volume (30 Days)
- DMRC 169.5K
- NVCT 121.5K
- Earning Date
- DMRC 10-30-2025
- NVCT 11-04-2025
- Dividend Yield
- DMRC N/A
- NVCT N/A
- EPS Growth
- DMRC N/A
- NVCT N/A
- EPS
- DMRC N/A
- NVCT N/A
- Revenue
- DMRC $33,663,000.00
- NVCT N/A
- Revenue This Year
- DMRC N/A
- NVCT N/A
- Revenue Next Year
- DMRC $7.63
- NVCT N/A
- P/E Ratio
- DMRC N/A
- NVCT N/A
- Revenue Growth
- DMRC N/A
- NVCT N/A
- 52 Week Low
- DMRC $6.81
- NVCT $4.44
- 52 Week High
- DMRC $48.32
- NVCT $11.52
- Technical
- Relative Strength Index (RSI)
- DMRC 32.49
- NVCT 49.22
- Support Level
- DMRC $7.81
- NVCT $5.86
- Resistance Level
- DMRC $7.94
- NVCT $6.22
- Average True Range (ATR)
- DMRC 0.65
- NVCT 0.34
- MACD
- DMRC -0.18
- NVCT -0.00
- Stochastic Oscillator
- DMRC 15.88
- NVCT 41.04
About DMRC Digimarc Corporation
Digimarc Corp is engaged in digital watermarking technologies. The Digimarc Illuminate platform is a distinctive software as a service (SaaS) cloud-based platform for digital connectivity that provides the tools for the application of digital watermarks and dynamic Quick Response (QR) codes, software (digital twins) that enables various systems and devices to interact with those data carriers and a centralized platform for capturing insights about digital interactions and automating activities based on that information. The company generates revenue through commercial and government applications of its technology. The company derives its revenue from software development services, subscriptions for products and related services, and licensing of patents.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.